Nov. 8, 2022
The medical imaging field has hit a major milestone with more than 200 FDA cleared Artificial Intelligence (AI) products now available on the market. This is a significant increase from just 50 cleared AI medical imaging products just at the end of November 2019. This growth in the AI medical imaging space is a clear indication of the increase in investment and efforts being put into bringing AI technology to the healthcare industry.

The availability of more than 200 FDA cleared AI medical imaging products presents numerous opportunities for healthcare providers to leverage AI technology to improve patient care and outcomes.

If you're interested in learning more about the current state of AI medical imaging, be sure to check out the DSI's AI-Central resource at https://aicentral.acrdsi.org/.

Related ACR News

  • State Legislative Bills Report

    As most state legislatures end their 2025 sessions and look to 2026, ACR staff is looking at how some radiology-specific bills they tracked fared this year.

    Read more
  • Medicare Payment Increase in Final Budget Reconciliation Bill

    The bill includes a 2.5% increase to the Medicare Physician Fee Schedule for calendar year 2026.

    Read more
  • CMS Announces Prior Authorization Test Model

    WiSer is a six-year program that will begin in six states on January 1, 2026. It will introduce prior authorization using AI technology for a select number of services, including some IR procedures.

    Read more